SE8205482D0 - Nya mellanprodukter for framstellning av antibakteriella cefalosporinsyror - Google Patents

Nya mellanprodukter for framstellning av antibakteriella cefalosporinsyror

Info

Publication number
SE8205482D0
SE8205482D0 SE8205482A SE8205482A SE8205482D0 SE 8205482 D0 SE8205482 D0 SE 8205482D0 SE 8205482 A SE8205482 A SE 8205482A SE 8205482 A SE8205482 A SE 8205482A SE 8205482 D0 SE8205482 D0 SE 8205482D0
Authority
SE
Sweden
Prior art keywords
manufacture
new intermediates
formula
antibacterial cephalosporin
acids
Prior art date
Application number
SE8205482A
Other languages
English (en)
Other versions
SE8205482L (sv
Inventor
T Naito
J Okumura
H Kamachi
S Iimura
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/771,859 external-priority patent/US4103085A/en
Priority claimed from US05/777,986 external-priority patent/US4112228A/en
Priority claimed from US05/788,056 external-priority patent/US4104469A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8205482L publication Critical patent/SE8205482L/sv
Publication of SE8205482D0 publication Critical patent/SE8205482D0/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8205482A 1976-07-13 1982-09-24 Nya mellanprodukter for framstellning av antibakteriella cefalosporinsyror SE8205482D0 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70522676A 1976-07-13 1976-07-13
US05/771,859 US4103085A (en) 1977-02-24 1977-02-24 7-(Syn-α-alkoxy-iminofurylacetamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US05/777,986 US4112228A (en) 1976-07-13 1977-03-16 7-(D-α-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo-[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives
US05/788,056 US4104469A (en) 1977-04-15 1977-04-15 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids

Publications (2)

Publication Number Publication Date
SE8205482L SE8205482L (sv) 1982-09-24
SE8205482D0 true SE8205482D0 (sv) 1982-09-24

Family

ID=27505490

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7708053A SE7708053L (sv) 1976-07-13 1977-07-11 Nya antibakteriella cefalosporinsyror
SE8205482A SE8205482D0 (sv) 1976-07-13 1982-09-24 Nya mellanprodukter for framstellning av antibakteriella cefalosporinsyror

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7708053A SE7708053L (sv) 1976-07-13 1977-07-11 Nya antibakteriella cefalosporinsyror

Country Status (16)

Country Link
JP (1) JPS5328191A (sv)
AU (1) AU511805B2 (sv)
BE (1) BE856785A (sv)
CA (1) CA1142918A (sv)
CH (1) CH640239A5 (sv)
DE (1) DE2731724A1 (sv)
DK (1) DK143344C (sv)
FI (1) FI772179A (sv)
FR (1) FR2358411A1 (sv)
GB (1) GB1561236A (sv)
GR (1) GR81280B (sv)
IE (1) IE45548B1 (sv)
LU (1) LU77756A1 (sv)
NL (1) NL7707820A (sv)
SE (2) SE7708053L (sv)
YU (1) YU171977A (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0228061A3 (en) * 1985-12-23 1988-12-14 Takeda Chemical Industries, Ltd. Cephem compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946000A (en) * 1973-10-31 1976-03-23 Bristol-Myers Company 7-[α-(2-Aminomethyl-1-cyclohexenyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids

Also Published As

Publication number Publication date
DK312677A (da) 1978-01-14
IE45548B1 (en) 1982-09-22
FI772179A (sv) 1978-01-14
SE7708053L (sv) 1978-01-14
LU77756A1 (sv) 1978-02-08
DK143344B (da) 1981-08-10
CA1142918A (en) 1983-03-15
AU2698277A (en) 1979-01-18
DK143344C (da) 1981-12-14
DE2731724A1 (de) 1978-01-19
GB1561236A (en) 1980-02-13
SE8205482L (sv) 1982-09-24
FR2358411A1 (fr) 1978-02-10
FR2358411B1 (sv) 1981-06-12
NL7707820A (nl) 1978-01-17
CH640239A5 (en) 1983-12-30
AU511805B2 (en) 1980-09-04
JPS5328191A (en) 1978-03-16
IE45548L (en) 1978-01-13
BE856785A (fr) 1978-01-13
GR81280B (sv) 1984-12-11
YU171977A (en) 1982-06-30

Similar Documents

Publication Publication Date Title
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
SE7510196L (sv) Sett att framstella nya 2,3-dihydro-1-bensotiepin-4-karboxylsyraamider
ATE31927T1 (de) (4-oxo-4h-(1)-benzopyran-8-yl)-alkansaueren, salze und derivate, herstellung und diese enthaltende arzneimittel.
DK77981A (da) Cephalosporinderivater samt fremgangsmaade til fremstilling deraf
SE8204893D0 (sv) Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra
SE7612053L (sv) Forfarande for framstellning av enolderivat
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
ATE1586T1 (de) Cephalosporinderivate, deren herstellung und die entsprechenden pharmazeutischen praeparate.
MC2021A1 (fr) Preparation de derives acyliques utilisables notamment pour la fabrication de medicaments
IL35875A0 (en) New pharmaceutical compositions for the treatment of microbial infections containing a glutamic acid derivative
SE8205482D0 (sv) Nya mellanprodukter for framstellning av antibakteriella cefalosporinsyror
DK237483A (da) Fremgangsmaade til fremstilling af propionsyrederivater
SE7909514L (sv) Nya halofenyl-pyridyl-allylaminderivat
SE7909501L (sv) Cefalosporin-antibiotika
GB1547473A (en) Cephalosporin compounds
ATE1551T1 (de) Cephemderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen.
ATE32724T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
SE7612963L (sv) Tienamycinderivat
SE7709646L (sv) Antibakteriella medel
SE7908439L (sv) Nya beta-laktonderivat av 2-hydroxicyklopentankarboxylsyra, sett for framstellning och anvendning derav som lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
ES398802A1 (es) Procedimiento para la preparacion de acidos propionicos sustituidos por fenilo en la posicion 2.
ATE2527T1 (de) Thienylbenzoesaeurederivate, verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen.
SE7902724L (sv) Substituerade n-iminometylpiperidiner
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
SE7610722L (sv) Nya cefalosporiner

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8205482-6